Neuroprotective Effects of Glucosamine in Huntington’s Disease Through NLRP3 Inflammasome Inhibition

Journal of Neuroimmune Pharmacology · Published 2025-11-15 · DOI 10.1007/s11481-025-10265-8

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s11481-025-10265-8

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Gallic Acid Alleviates Cerebral Ischemia–reperfusion Injury in Mice by Mediating Microglial Polarization Through the NLRP3/mTOR Axis · Journal of Neuroimmune Pharmacology · 2025 · Same journal
• Neuroimmune Correlates of HIV and Marijuana Use: Peripheral Biomarkers and Cognitive Function · Journal of Neuroimmune Pharmacology · 2026 · Same journal
• Targeting IL-33 in Precision Neuroimmunology: Cellular Mechanisms and Therapeutic Strategies for CNS Disorders · Journal of Neuroimmune Pharmacology · 2026 · Same journal
• Comparative Study on the Neuroprotective Effects of Perindopril and Benazepril in Experimentally-induced Chronic Mild Stress in Rats · Journal of Neuroimmune Pharmacology · 2025 · Same journal
• Protective Effects of Pomiferin on Aluminum Chloride-induced Memory Impairment: Evidence from Behavioral, Biochemical, and Insilico Studies · Journal of Neuroimmune Pharmacology · 2026 · Same journal
• Temporin-1CEa and its Analog LK2(6)A(L) Confer Neuroprotective Effects in Parkinson’s Disease Model by Attenuating Neuroinflammation Via the NF-κB and MAPK Signaling Pathways · Journal of Neuroimmune Pharmacology · 2025 · Same journal
• Ameliorative Effect of Vitamin C Against Tramadol-Induced Learning and Memory Impairment in Juvenile Rat Via Attenuation of Oxidative Stress and Dysfunctional Synaptic Plasticity · Journal of Neuroimmune Pharmacology · 2025 · Same journal
• Profiling the Cerebrospinal Fluid Proteome in Progressive Multiple Sclerosis: Treatment Effects and Associations with IgM Oligoclonal Bands · Journal of Neuroimmune Pharmacology · 2025 · Same journal
• Pyrimidine Derivative, (E)-N-[4-(4-Chlorophenyl)-6-(4-Methylphenyl)Pyrimidin-2-yl]-1-(Furan-2-yl)Methanimine, Named BN5 Ameliorates Cognitive Dysfunction and Regulates esr1 and esr2b Expression in Female In Vivo Zebrafish Alzheimer Model · Journal of Neuroimmune Pharmacology · 2025 · Same journal
• S-Ketamine Alleviates Anxiety-Induced Chronic Postoperative Pain by Affecting Glucose Metabolism of Striatal Microglia in a Rat Model · Journal of Neuroimmune Pharmacology · 2025 · Same journal